1. Home
  2. DTSS vs PFSA Comparison

DTSS vs PFSA Comparison

Compare DTSS & PFSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datasea Inc.

DTSS

Datasea Inc.

HOLD

Current Price

$1.10

Market Cap

10.9M

Sector

Technology

ML Signal

HOLD

PFSA

Profusa Inc.

N/A

Current Price

$3.16

Market Cap

8.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DTSS
PFSA
Founded
2014
2009
Country
China
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.9M
8.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DTSS
PFSA
Price
$1.10
$3.16
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
129.4K
241.9K
Earning Date
02-11-2026
04-02-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$64,349,277.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
68.56
122.22
52 Week Low
$0.64
$2.90
52 Week High
$2.89
$957.00

Technical Indicators

Market Signals
Indicator
DTSS
PFSA
Relative Strength Index (RSI) 51.36 92.70
Support Level $0.82 $0.05
Resistance Level $1.15 $4.22
Average True Range (ATR) 0.17 0.15
MACD -0.00 0.35
Stochastic Oscillator 33.68 71.30

Price Performance

Historical Comparison
DTSS
PFSA

About DTSS Datasea Inc.

Datasea Inc is a technology company that operates in two main segments. The first segment, Acoustic High-Tech, focuses on developing and applying acoustic technologies, such as ultrasound, infrasound, and mechanical wave effects, for applications like ultrasonic sterilization, neuro-regulation, acupoint stimulation, and environmental purification. The second segment, AI Multimodal Digitalization, integrates artificial intelligence with 5G networks and big data processing to create a proprietary multimodal data platform that combines text, voice, image, and video for real-time intelligent analysis and generation. The company generates all of its revenue from the People's Republic of China (PRC).

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

Share on Social Networks: